Results 81 to 90 of about 5,134 (265)

Update on Menopause Hormone Therapy; Current Indications and Unanswered Questions

open access: yesClinical Endocrinology, EarlyView.
ABSTRACT Objective To provide clinicians involved in managing menopause with a summary of current evidence surrounding menopause hormone therapy (MHT). Design The authors evaluate and synthesize existing pooled evidence relating to MHT's clinical indications, efficacy, and safety and explore the limitations of existing data. Patients The review focuses
Annice Mukherjee, Susan R. Davis
wiley   +1 more source

Resolution of the First Ukrainian endometriosis forum “Drug treatment for endometriosis-associated pelvic pain. The quality of a woman’s life”

open access: yesРепродуктивная эндокринология, 2023
Endometriosis affects 10% of all women of reproductive age, i.e. 190 million patients. Ukraine currently does not gather statistics on the incidence of endometriosis, but, at a rough estimate, this number is approximately 280 thousand women and the real ...
A.V. Boichuk   +11 more
doaj   +1 more source

Regarding the evidence-based use of micronized progesterone

open access: yesРепродуктивная эндокринология, 2020
An issue of habitual miscarriage poses a high social importance especially during COVID-19 pandemic. Meanwhile, healthcare workers faced a mass media campaign against using micronized progesterone upon habitual miscarriage, which, as viewed by ...
A. D. Makatsariya   +2 more
doaj   +1 more source

Combined effect of dydrogesterone and letrozole on humoral immune function, sex hormone levels and serology-related indices in patients with endometriosis [PDF]

open access: yes, 2019
Purpose: To investigate the combined effect of dydrogesterone and letrozole on humoral immunity, and levels of sex hormones and serology-related indices in patients with endometriosis.Methods: Patients with endometriosis (98 cases) were randomly assigned
Huang, Xiaoping   +2 more
core   +2 more sources

O-150 Birth defects reporting and the use of oral dydrogesterone in assisted reproductive technology : a global pharmacovigilance study

open access: yesHuman Reproduction, 2023
Is dydrogesterone exposure during early pregnancy associated with the reporting of birth defects ? We observed an increased reporting of birth defects, such as congenital heart defects and hypospadias, with dydrogesterone, especially ...
A. Henry   +4 more
semanticscholar   +1 more source

A comparison of the treatment outcome of Asherman's syndrome which developed within and outside the puerperal period: A matched cohort study

open access: yesActa Obstetricia et Gynecologica Scandinavica, Volume 104, Issue 4, Page 774-780, April 2025.
Following hysteroscopic adhesiolysis, the outcome of Asherman's syndrome in women who developed the condition in the puerperal period was worse than those who developed the condition outside the puerperal period. Strategies to minimize damage and promote regeneration of the endometrium in the puerperal period in women at risk of developing intrauterine
Lingling Yang   +7 more
wiley   +1 more source

Age-related diseases and menopausal hormone therapy – focus on progestogens

open access: yesЛечащий Врач, 2022
Hormone therapy is the most effective treatment for menopausal symptoms. The benefits of using menopausal hormone therapy outweigh the risks for healthy women. However, the situation is more complicated in women with one or more chronic diseases.
E. N. Kareva
doaj   +1 more source

Comparative study of dydrogesterone dosage of the duphaston 40mg daily and duphaston 20mg daily in the outcome of pregnancy with threatened miscarriage in husm. [PDF]

open access: yes, 2011
Objective To evaluate the effectiveness and the adverse effect of Duphaston 40mg daily and Duphaston 20mg daily in threatened miscarriage. Methodology This is a prospective randomized controlled trial conducted at Hospital USM, Kubang Kerian Kelantan ...
Abd Rahim, Rahimah
core  

Cost-effectiveness of infant pneumococcal vaccination in the Netherlands [PDF]

open access: yes, 2013
Objectives: The Dutch National Immunization Program offers the 10-valent pneumococcal conjugate vaccine (PCV10). Also licensed for use in the infant population is the 13-valent PCV (PCV13). To update cost-effectiveness (CE) estimates of PCV13 over PCV10,
Postma, M.J., Vemer, P.
core   +1 more source

Effective post-laparoscopic treatment of endometriosis with dydrogesterone

open access: yesGynecological Endocrinology, 2007
An open, prospective, multicenter study was designed to assess the efficacy and safety of dydrogesterone in the post-laparoscopic treatment of endometriosis in Indian patients. Ninety-eight patients suffering from minimal, mild, moderate or severe endometriosis, with or without infertility, who had undergone laparoscopy, were treated with ...
Kamala Selvaraj   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy